Next Article in Journal

The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers

Next Article in Special Issue

Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy

Previous Article in Journal

Tunnelled Peritoneal Catheter for Malignant Ascites—An Open-Label, Prospective, Observational Trial

Previous Article in Special Issue

Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessReview

Article Versions Notes

Cancers 2021, 13(12), 2924; https://doi.org/10.3390/cancers13122924

Action	Date	Notes	Link
article xml file uploaded	11 June 2021 11:43 CEST	Original file	-
article xml uploaded.	11 June 2021 11:43 CEST	Update	https://www.mdpi.com/2072-6694/13/12/2924/xml
article pdf uploaded.	11 June 2021 11:43 CEST	Version of Record	https://www.mdpi.com/2072-6694/13/12/2924/pdf
article html file updated	11 June 2021 11:45 CEST	Original file	-
article html file updated	26 July 2022 23:53 CEST	Update	-
article html file updated	2 September 2025 10:41 CEST	Update	https://www.mdpi.com/2072-6694/13/12/2924/html

Back to TopTop